Quantitatively evaluation of arsenic toxicity on a traditional Chinese patent medicine Niuhuang Jiedu Tablets by general ICP-MS and HPLC-ICP-MS
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: JIN, Pengfei (Beijing Hospital, Phamacy department, Beijing, China)
- Co-author(s): Kuang, Yongmei (Beijing Hospital, Beijing, China)
Hu, Xin (Beijing Hospital, Beijing, China)
Zou, Ding (Beijing Hospital, Beijing, China)
Niuhuang Jiedu Tablets (NHJDT) is a traditional Chinese patent medicine which contains the mineral drug of realgar (with As2S2 as main constituent) in its formulation. Since increasing cases of arsenic poisoning induced by NHJDT were reported in recent years, the evaluation of arsenic toxicity of NHJDT was critical to its clinical.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.